Hirano S, Masuda N, Oda H
J Lipid Res. 1981 Jul;22(5):735-43.
Nine fecal samples from four healthy subjects were examined for their ability to transform chenodeoxy-cholic acid (CDCA) and ursodeoxycholic acid (UDCA) in in vitro anaerobic broth cultures. Seven samples converted CDCA and UDCA into each other (more than 50% of CDCA was converted into UDCA while 10% or less of UDCA was converted into CDCA), and produced 7-keto-lithocholic acid and lithocholic acid equally from both acids. No alteration of the 7 beta-hydroxy group of UDCA was demonstrated by two fecal samples that failed to perform mutual 7-epimerization, suggesting the conversion of UDCA into lithocholic acid via CDCA. The 3 alpha-hydroxy groups of these substrate and metabolite bile acids were invariably partially epimerized to 3 beta-hydroxy groups by all the fecal samples. Evidence is presented for the prevalence of these 7- and 3-epimerizing organisms among the human intestinal flora.
对来自四名健康受试者的九份粪便样本进行了检测,以评估其在体外厌氧肉汤培养物中转化鹅去氧胆酸(CDCA)和熊去氧胆酸(UDCA)的能力。七份样本将CDCA和UDCA相互转化(超过50%的CDCA转化为UDCA,而10%或更少的UDCA转化为CDCA),并且从这两种酸中均等量产生7-酮石胆酸和石胆酸。两份未能进行相互7-差向异构化的粪便样本未显示UDCA的7β-羟基发生改变,这表明UDCA通过CDCA转化为石胆酸。所有粪便样本均将这些底物和代谢物胆汁酸的3α-羟基部分差向异构化为3β-羟基。有证据表明这些7-和3-差向异构化微生物在人类肠道菌群中普遍存在。